ArticleOncoimmunology2016

Anti-CD137 enhances anti-CD20 therapy of systemic B-cell lymphoma with altered immune homeostasis but negligible toxicity.

Fernando Souza-Fonseca-Guimaraes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.